AbCellera Biologics (ABCL) Non-Current Deffered Revenue (2020 - 2026)
AbCellera Biologics' Non-Current Deffered Revenue was $178.25 million in Q2 2026, up 6.4% from $167.53 million a year earlier and up 1.2% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at AbCellera Biologics came in at $174.45 million, up 16.4% from FY2024.
- Non-Current Deffered Revenue has now increased for three consecutive years, with a five-year compound annual growth rate of 46.5% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $149.89 million in FY2024 (+56.3%), $95.92 million in FY2023 (+391.5%), $19.52 million in FY2022 (-28.8%) and $27.41 million in FY2021 (+5.9%).
- The Q2 2026 figure marks the highest quarterly Non-Current Deffered Revenue in data going back to Q4 2020.
- Compared with a year earlier, Non-Current Deffered Revenue has increased for five straight quarters, with growth averaging 130.3% over the last seven quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q3 2024 (growth of 767.1%); the worst was Q3 2023 (a decline of 73.7%).
- Per Business Quant data, ABCL's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $176.11 million (Q1 2026), $174.45 million (Q4 2025) and $169.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | - |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 178.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178.25 Mn |
| Mar 31, 2026 | 176.11 Mn |
| Dec 31, 2025 | 174.45 Mn |
| Sep 30, 2025 | 169.12 Mn |
| Jun 30, 2025 | 167.53 Mn |
| Mar 31, 2025 | 157.19 Mn |
| Dec 31, 2024 | 149.89 Mn |
| Sep 30, 2024 | 142.05 Mn |
| Jun 30, 2024 | 124.19 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 95.92 Mn |
| Sep 30, 2023 | 16.38 Mn |
| Jun 30, 2023 | 27.72 Mn |
| Mar 31, 2023 | 25.42 Mn |
| Dec 31, 2022 | 19.52 Mn |
| Sep 30, 2022 | 62.20 Mn |
| Jun 30, 2022 | 64.80 Mn |
| Mar 31, 2022 | 64.15 Mn |
| Dec 31, 2021 | 27.41 Mn |
| Sep 30, 2021 | 59.68 Mn |
API Access
AbCellera Biologics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();